Identity & access
Role-based access, least privilege and controlled workspaces.
+BioMedAna Trust Center
Move faster.
Keep the evidence.
BioMedAna is SOC 2 compliant and designed so bioprocess intelligence remains secure, reviewable and accountable from source record to scientific decision.
CONTROL STATUSALL SYSTEMS GOVERNED
SOC 2 compliant foundationContinuously monitored access, lineage and review controls
01
IdentityAuthenticated access, least privilege
✓02
EvidenceSource lineage preserved end to end
✓03
ModelVersion-aware, controlled releases
✓04
DecisionHuman review and approval required
✓DECISION RECORDCandidate operating region
APPROVEDAccess controlledLineage preservedReview required
01 — CONTROL FOLLOWS THE CHAIN
Trust should travel with the intelligence.
BioMedAna does not treat security as a perimeter around a black box. Identity, lineage, version and review context stay attached as the process moves from evidence to recommendation.
RECORD · BA-2417Source evidence
- Identity
- Lineage
- Version
- Review
Identity attachedSigned in · ELN user mchen · read scope
02 — GATES, NOT GUESSWORK
Every recommendation passes
through the same gates.
Nothing moves from evidence to action without lineage, version control, explicit uncertainty and a human approval step. The gates are the product, not an afterthought.
EVIDENCESource records
Runs, assays, materials — authenticated and versioned
✓Lineage attached
MODELVersioned model
Configuration, training evidence and validation history
✓Release controlled
RECOMMENDATIONProposed action
Prediction, uncertainty and constraints made explicit
✓Uncertainty shown
REVIEWHuman approval
Scientist reviews evidence before anything moves
✓Approval required
AUDIT TRAILEvery step above is recorded — who, what, when, with which evidence and model version.
03 — ENTERPRISE CONTROLS
Built for serious science at scale.
Practical controls for sensitive process data, governed models and accountable workflows.
Skip card journey ↓Trust controls in practice01 / 06 ↓ SCROLL TO EXPLORE 01 02 03 04 05 06
Data provenance
Source-to-decision lineage for records, calculations and model outputs.
+Model lifecycle
Version-aware configurations, review history and controlled releases.
+Human review
Evidence and approval context before consequential scientific action.
+Operational resilience
Monitored service operations, backups and recovery practices.
+Environment control
Clear separation between development, validation and production contexts.
+04 — SHARED RESPONSIBILITY
Clear platform controls.
Clear customer ownership.
BioMedAna provides the platform safeguards; each customer retains responsibility for intended use, validation scope, access policy and regulated procedures.
- Secure platform and service operations
- Workspace, role and access controls
- Evidence, model and decision lineage
- System activity and review mechanisms
- Intended use and risk classification
- Validation and qualification strategy
- User access, procedures and retention
- Final scientific and quality decisions
05 — DEPLOYED WITHOUT A RIP-AND-REPLACE
Target value in 8–12 weeks.
Not a year-long transformation.
BioMedAna is designed to meet data where it already lives, configure around the customer's process, and deliver measurable value without requiring a platform overhaul.
W1W2W3W4W5W6W7W8W9W10W11W12
ConnectWEEKS 1–2
Priority sources connected, read-only, in your environment
ContextualizeWEEKS 2–5
Runs, materials, events and assays aligned into scientific records
First modelsWEEKS 5–9
Baseline predictions validated against held-out historical runs
Governed decisionWEEKS 9–12
First evidence-linked recommendation reviewed in a real workflow
ILLUSTRATIVE 12-WEEK SHAPE — SCOPE AGREED PER DEPLOYMENTMilestone: first governed, evidence-linked decision ✓
06 — SECURITY REVIEW
The materials your team needs to evaluate BioMedAna.
We support focused security, architecture and governance reviews with materials matched to the deployment conversation.
Request the review package ↗Security overview
↗Platform boundaries, service architecture and control approach
SOC 2 materials
↗Current compliance documentation available under appropriate terms
Data-flow review
↗Sources, workspaces, isolation and deployment-specific boundaries
Governance mapping
↗Evidence lineage, model lifecycle, review and approval controls
07 — QUESTIONS WE GET OFTEN
Straight answers before the pilot.
Is BioMedAna SOC 2 compliant?
Yes. BioMedAna is built on the OpenAna platform foundation, which is SOC 2 compliant. Security materials are available on request.
Can BioMedAna operate in a validated GxP environment?
BioMedAna provides the platform controls — access, lineage, versioning and audit trails — that validated environments require. Validation scope, qualification protocols and intended-use classification remain the customer's responsibility.
Does BioMedAna make decisions automatically?
No. Every Twin recommendation is presented with evidence, uncertainty and a required human review and approval step before it informs a scientific or manufacturing decision.
Where does our process data live?
Access, workspace isolation and data boundaries are configured per deployment. Multi-program and CDMO customers can isolate client data while still reusing platform-level intelligence.
Trust starts before deployment
Bring security and science into the same room.
Request the current trust materials and map BioMedAna to your deployment and validation needs.
Start a trust review ↗